These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 22187284)
1. The search for effective therapy for sepsis: back to the drawing board? Angus DC JAMA; 2011 Dec; 306(23):2614-5. PubMed ID: 22187284 [No Abstract] [Full Text] [Related]
2. Activated protein C (Xigris): a drug in trouble. Vangerow B; Mignini MA Acta Anaesthesiol Scand; 2007 Feb; 51(2):261-2. PubMed ID: 17261152 [No Abstract] [Full Text] [Related]
3. Trial watch: Sepsis study failure highlights need for trial design rethink. Tse MT Nat Rev Drug Discov; 2013 May; 12(5):334. PubMed ID: 23629495 [No Abstract] [Full Text] [Related]
4. Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approach. Kimmoun A; Levy B Shock; 2011 Dec; 36(6):633-4. PubMed ID: 22089128 [No Abstract] [Full Text] [Related]
5. Treating sepsis. Wenzel RP N Engl J Med; 2002 Sep; 347(13):966-7. PubMed ID: 12324551 [No Abstract] [Full Text] [Related]
6. Risks and benefits of activated protein C treatment for severe sepsis. Warren HS; Suffredini AF; Eichacker PQ; Munford RS N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562 [No Abstract] [Full Text] [Related]
7. New mode of intervention in sepsis treatment. Foubister V Drug Discov Today; 2003 Jul; 8(14):610-2. PubMed ID: 12867140 [No Abstract] [Full Text] [Related]
8. Targeting the coagulation cascade in sepsis: did we find the "magic bullet"? Mathiak G; Neville LF; Grass G Crit Care Med; 2003 Jan; 31(1):310-1. PubMed ID: 12545036 [No Abstract] [Full Text] [Related]
9. The Sepsis Saga: Consensus to Xigris. Dries DJ Air Med J; 2016; 35(4):194-6. PubMed ID: 27393750 [No Abstract] [Full Text] [Related]
10. [Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice]. Dhainaut JF; Payen DM; Bernardin G; Gérard JL; Martin C; Perrotin D; Regnier B Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():53-64. PubMed ID: 15359946 [No Abstract] [Full Text] [Related]
11. Severe sepsis and therapy with activated protein C. Parrillo JE N Engl J Med; 2005 Sep; 353(13):1398-400. PubMed ID: 16192486 [No Abstract] [Full Text] [Related]
12. [Xigris and corticoids: what are the perspectives for the patient with severe sepsis?]. Annane D Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():43-5. PubMed ID: 15359943 [No Abstract] [Full Text] [Related]
13. Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies. Barochia A; Solomon S; Cui X; Natanson C; Eichacker PQ Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):479-94. PubMed ID: 21323610 [TBL] [Abstract][Full Text] [Related]
14. Meeting unmet needs in patients with sepsis: the role of drotrecogin alfa (activated). Morris PE Am J Crit Care; 2003 Mar; 12(2):94-7. PubMed ID: 12625165 [No Abstract] [Full Text] [Related]
15. Activated protein C (Xigris) treatment in sepsis: a drug in trouble. Gårdlund B Acta Anaesthesiol Scand; 2006 Sep; 50(8):907-10. PubMed ID: 16923083 [TBL] [Abstract][Full Text] [Related]
16. Xigris: reducing mortality in adult patients with severe sepsis. Larson AM Urol Nurs; 2002 Jun; 22(3):200-1. PubMed ID: 12087796 [No Abstract] [Full Text] [Related]
17. Drotrecogin alfa (activated) in severe sepsis. Friedrich JO N Engl J Med; 2006 Jan; 354(1):94-6; author reply 94-6. PubMed ID: 16394311 [No Abstract] [Full Text] [Related]
18. Prescribing indications based on successful clinical trials in sepsis: a difficult exercise. Carlet J Crit Care Med; 2006 Feb; 34(2):525-9. PubMed ID: 16424736 [No Abstract] [Full Text] [Related]
19. Management of sepsis. Mackenzie AF; Bartelink AK N Engl J Med; 2007 Mar; 356(11):1179; author reply 1181-2. PubMed ID: 17361493 [No Abstract] [Full Text] [Related]
20. How to ENHANCE our knowledge of activated protein C during pediatric sepsis trials: pediatric versus adult trials. Hazelzet JA Pediatr Crit Care Med; 2006 May; 7(3):277-8. PubMed ID: 16682888 [No Abstract] [Full Text] [Related] [Next] [New Search]